Publication | Open Access

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirologyDose-escalation TrialMedicineVaccine ResearchPhase 1Covid-19